Today's top medical abstracts
Internal Med
Become a Member Today!
Email
Password
Remember me
Forgot your Password?

Invite Code?

Home
General Internal Med
Messages
Conferences
Jobs
Newsletters
My Library
Topics in
Internal Med
        Academic Med/Education
        Adolescent Medicine
        Allergy/Immunology
        Atherosclerosis/Lipids
        Basic Science/Genetics
        Cardiology
        Clinical Pharmacology
        Complementary Medicine
        Critical Care/
    Hospitalist
        Dermatology
        Economics of Medicine
        Endocrinology
        Epidemiology
        Gastroenterology
        Geriatrics
        Hematology/Oncology
        Infectious Disease
        Nephrology/Urology
        Neurology
        Orthopedic/Physical Med
        Popular Press
        Preventive Medicine
        Primary Care
        Psychiatry
        Pulmonology
        Radiology/Diagnostics
        Rheumatology
        Sports Medicine
        Vascular Medicine
        Women`s Health
 
Help
Resource Center
RSS News Feeds
Send Newsletter
to a Friend
 
Sponsor
Cancer Science: #14. Does Size Matter? "Stumpy" Telomeres Allow Cancer Cells to Evade Senescence
Sara Hartley, MDLinx Oncology
  See all
4-year bone mineral density changes;changes in soft tissue composition Article Summary

Click the title below to leave the MDLinx Network and go to the Journal's Website
Changes in soft tissue composition are the primary predictors of 4-year bone mineral density changes in postmenopausal women
Osteoporosis International, 07/15/08
Print     Email This Article     Save in My Library   Free Abstract
Milliken LA et al. - Body composition changes are important positive predictors of BMD changes independent of EX and CA supplementation, but their contribution varies according to bone site and with HT use.

Methods
  • Study to examine the relationship between changes in body weight and composition and changes in 4-year BMD after accounting for age, exercise, and calcium supplement intake (CA) in postmenopausal women with and w/o hormone therapy
  • Postmenopausal women (aged 40–65 yrs) either using HT (for 1–3.9 yrs) or not using HT (for ≥1 year) were recruited to the study
  • EX and CA was monitored throughout the study and 167 women completed 4 yrs
  • BMD and soft tissue composition measurements were made using dual-energy X-ray absorptiometry
  • Regression was used to predict 4-yr BMD changes from EX, CA, age, baseline and 4-yr changes in body weight and composition
  • HT users, and non-users were analyzed separately

Results
  • The models predicting regional BMD changes that included soft tissue composition changes explained the most variation vs those with body weight or EX and CA alone
  • Larger amounts of variation in BMD changes were explained in the no HT group

Sponsor
Read a Different Specialty
Allergy/Immunology
Anesthesiology
Cardiology
Dermatology
Drugs
Emergency Medicine
Endocrinology
ENT
Family Medicine
Gastroenterology
Hematology-Oncology
Infectious Disease
Internal Medicine
Nephrology
Neurology
OB/Gyn
Ophthalmology
Orthopedics
Pediatrics
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology
Profession Index
Dentist
Hospital Administrator
Nurse
    Medical Students
Nurse Practitioner
Pharma/Drug Marketer
    Pharmacist
Physician
Physician Assistants
Article Search
Keyword:
Search:
Published within:
Sort By:
Date Relevance
    
Sponsor
About MDLinx  |  Contact  |  Advertise with MDLinx  |  Site Map  |  Privacy Policy  |  Terms of Use  |  Sign Up For Newsletters  |  Recommend this Site

English |  Español |  Français |  Deutsch |  中文 |  Руccкий |  Norsk |  Nederlands |  Português |  Italiano

©1999-2008 MDLinx, Inc.